drugset / Trial / NCT00003205

Bryostatin 1 in Treating Patients With Stage IV Breast Cancer

NCT00003205

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with stage IV breast cancer.

Timeline

Start
1998-04
Primary completion
2004-04
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject bryostatin 1 Small molecule Intravenous

Indications